BrightSpring Health Services, Inc. Common Stock
BTSGNASDAQ · Healthcare · Medical - Healthcare Information ServicesBrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States.
$71.21-0.34%
报价 2026-11-13
市值
$14.17B
EV
$15.02B
PE (TTM)
40.9x
预期 PE (FY2026)
37.1x
52 周区间距高点 -2.3%
$31.36$72.91
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool
爆发潜力
2026-11-13未命中✗ 收入线✗ EPS 线
| 财年 | 收入倍数 | EPS | PE |
|---|---|---|---|
| FY+22027-12 | 1.2x | 1.71 → 2.48(1.5x) | 28.7 |
| FY+32028-12 | 1.4x | 1.71 → 3.10(1.8x) | 23.0 |
毛利率 13% · TTM 收入 $15251M · 基数 EPS 1.71(调整后)
电话会信号
辅助标签Q3 20262026-10-30
扩产上调指引供不应求
指引 上调
信心 4
分析师 4
“We still anticipate and reiterate from Analyst Day at least 15% to 20% organic adjusted EBITDA growth in 2027.”
原文引用(3)
- 扩产:we are continuing to build capacity in our business over time
- 上调指引:Total adjusted EBITDA is now expected to be in the range of $850 million to $860 million for the full year 2026.
- 供不应求:Demand for services continues to outstrip our ability to provide them
蓝色标签在暴涨研究中略有区分度;悬停查看口径。
研究结论
还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| BTSGBrightSpring Health Services, Inc. Common Stock | $14.17B | -0.3% | +25.7% | 12.3% | 40.9x | 21.2x | 27.1x | |
| BRKRBruker Corporation | $9.41B | +2.1% | +3.4% | 49.1% | – | 90.1x | 38.9x | |
| KRYSKrystal Biotech, Inc. | $9.05B | -0.1% | +28.4% | 92.6% | 35.3x | 40.7x | 29.2x | |
| HQYHealthEquity, Inc. | $8.56B | +0.4% | +8.0% | 69.5% | 32.7x | 23.7x | 18.1x | |
| CHEChemed Corporation | $7.13B | -0.4% | +7.2% | 31.1% | 19.7x | 12.6x | 24.1x | |
| TFXTeleflex Incorporated | $6.15B | +1.3% | -31.3% | 53.3% | – | 63.6x | 15.9x | |
| RDNTRadNet, Inc. | $6.02B | +0.5% | +25.3% | 13.5% | – | 25.6x | – | |
| MMSIMerit Medical Systems, Inc. | $5.19B | -0.1% | +8.4% | 48.7% | 31.5x | 13.5x | 25.4x | |
| STVNStevanato Group S.p.A. | $4.32B | +10.0% | +8.1% | 29.1% | 24.6x | 12.3x | – | |
| 同行中位数 | – | – | +8.0% | 48.9% | 31.5x | 24.7x | 24.8x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
| Metric | 2026-09-30 Q3 2026 | 2026-06-30 Q2 2026 | 2026-03-31 Q1 2026 | 2025-12-31 Q4 2025 | 2025-09-30 Q3 2025 | 2025-06-30 Q2 2025 | 2025-03-31 Q1 2025 | 2024-12-31 Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.21B | $3.87B | $3.61B | $3.55B | $3.33B | $3.15B | $2.88B | $3.05B |
| Gross Margin | 12.3% | 12.7% | 13.3% | 11.6% | 11.8% | 11.9% | 11.8% | 13.8% |
| Operating Margin | 3.8% | 3.7% | 3.8% | 3% | 2.6% | 1.5% | 1.8% | 2.6% |
| Net Income | $100.1M | $86.7M | $74.4M | $77.1M | $55.8M | $28.2M | $29.5M | $16M |
| Diluted EPS | 0.45 | 0.39 | 0.34 | 0.35 | 0.26 | 0.13 | 0.14 | 0.08 |
| Operating Cash Flow | $204.3M | $43.9M | $122.9M | $231.6M | $107.9M | $49.1M | $101.6M | $90.6M |